Search Results

Recommended Child and Adolescent Immunization Schedule for ages 18 years or younger, United States 2024.

Subjects: Advisory Committees* ; Immunization Schedule* ; Vaccination*

• Source: JAAPA : official journal of the American Academy of Physician Assistants [JAAPA] 2024 Jan 01; Vol. 37 (1), pp. 1-15.Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 9513102 Publication Model: Print Cited Medium: Internet ISSN: 1547-1896

Record details

Migration and infant immunization timeliness in New Zealand: Evidence from the Growing Up in New Zealand study.

• Authors : Hashemi L; Social and Community Health, School of Population Health, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. Electronic address: .; Ghasemi M

Subjects: Immunization Programs* ; Vaccines*; Infant

• Source: Vaccine [Vaccine] 2024 Apr 02; Vol. 42 (9), pp. 2229-2238. Date of Electronic Publication: 2024 Mar 11.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Zero-Dose Immunization Programme reaches milestone.

• Authors : Burki T

Subjects: Immunization* ; Immunization Programs*; Humans

• Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Apr; Vol. 24 (4), pp. e228-e229.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Updated 2024 US vaccine recommendations from the Advisory Committee on Immunization Practices.

• Authors : Pereira MR

Subjects: Advisory Committees* ; Vaccines*; Immunization

• Source: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2024 Apr; Vol. 24 (4), Publisher: Elsevier Country of Publication: United States NLM ID: 100968638 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Observational analysis of the immunogenicity and safety of various types of spinal muscular atrophy vaccines.

• Authors : Sun G; Immunization Program Department, Daqing Center for Disease Control and Prevention, Daqing, 163000, Heilongjiang, China.; Wang G

Subjects: Poliomyelitis*/Poliomyelitis*/Poliomyelitis*/prevention & control ; Poliomyelitis*/Poliomyelitis*/Poliomyelitis*/chemically induced ; Poliovirus*

• Source: Inflammopharmacology [Inflammopharmacology] 2024 Apr; Vol. 32 (2), pp. 1025-1038. Date of Electronic Publication: 2024 Feb 03.Publisher: Birkhäuser Country of Publication: Switzerland NLM ID: 9112626 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Tolerability, safety, and immunogenicity of the novel oral polio vaccine type 2 in children aged 6 weeks to 59 months in an outbreak response campaign in The Gambia: an observational cohort study.

• Authors : Bashorun AO; MRC Unit The Gambia at the London School of Hygiene & Tropical Medicine, Banjul, The Gambia.; Kotei L

Subjects: Poliomyelitis*/Poliomyelitis*/Poliomyelitis*/prevention & control ; Poliovirus*; Humans

• Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Apr; Vol. 24 (4), pp. 417-426. Date of Electronic Publication: 2024 Jan 15.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Pneumococcal conjugate vaccination schedules in infants-acquisition, immunogenicity, and pneumococcal conjugate and yellow fever vaccine co-administration study: statistical analysis plan.

• Authors : Mackenzie GA; MRC Unit The Gambia at London School of Hygiene & Tropical Medicine, Fajara, The Gambia. .; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK. .

Subjects: Yellow Fever* ; Yellow Fever Vaccine*; Humans

• Source: Trials [Trials] 2024 Mar 26; Vol. 25 (1), pp. 216. Date of Electronic Publication: 2024 Mar 26.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

Record details

Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial.

• Authors : Ochoge M; MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Banjul, The Gambia.; Futa AC

Subjects: Poliomyelitis*/Poliomyelitis*/Poliomyelitis*/epidemiology ; Poliovirus*; Child, Preschool

• Source: Lancet (London, England) [Lancet] 2024 Mar 23; Vol. 403 (10432), pp. 1164-1175. Date of Electronic Publication: 2024 Feb 22.Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X

Record details

Vaccination patterns and up-to-date status of children 19-35 months, 2011-2021.

• Authors : Nguyen KH; Hubert Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA 30322, USA; Department of Epidemiology, George Washington University School of Public Health, Washington, DC 20037, USA. Electronic address: .

Subjects: Vaccination* ; Vaccines*; Child

• Source: Vaccine [Vaccine] 2024 Mar 07; Vol. 42 (7), pp. 1617-1629. Date of Electronic Publication: 2024 Feb 09.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Safety and immunogenicity of shorter interval schedules of the novel oral poliovirus vaccine type 2 in infants: a phase 3, randomised, controlled, non-inferiority study in the Dominican Republic.

• Authors : Rivera Mejía L; Fundación Dominicana de Perinatologia Pro Bebe, Hospital Universitario Maternidad Nuestra Señora de la Altagracia, Santo Domingo, Dominican Republic.; Peña Méndez L

Subjects: Poliovirus Vaccine, Oral* ; Poliovirus*; Infant

• Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Mar; Vol. 24 (3), pp. 275-284. Date of Electronic Publication: 2023 Dec 15.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details